Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant
Ruihao Huang(Army Medical University), Xi Zhang(Army Medical University), Sanbin Wang(117th Hospital of People's Liberation Army), Peiyan Kong(Army Medical University), Li Gao(Army Medical University), Jing Liu(Central South University), Ting Chen(Nanchang University), Yanqi Zhang(Iowa State University), Xiangyu Ma(Army Medical University), Cheng Zhang(Army Medical University), Jiang F. Zhong(University of Southern California), Yi Su, Lei Gao(Zhejiang Chinese Medical University), Jishi Wang(Guiyang Medical University)
Cited by 53
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro
|Acta Pharmacologica Sinica|2017|103
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90